// App-Quantinova.ai

P1124 : MOSUNETUZUMAB RETREATMENT IS EFFECTIVE AND WELL-TOLERATED IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL NON-HODGKIN LYMPHOMA

Researchers

Presenter

  • Chan Yoon Cheah

Principal Investigators

  • Nancy L. Bartlett

  • Sarit Assouline

  • Stephen J. Schuster

  • Won Seog Kim

  • Mazyar Shadman

  • Iris Isufi

  • Shen Yin

  • Michelle Y. Doral

  • Jason Sit

  • Vivian Chen

  • Huang Huang

  • Mingzhu Zhou

  • Michael C. Wei

  • L. Elizabeth Budde

Medical Centers

  • Samsung Medical Centre,Seoul,Corée, République De

  • Samsung Medical Center​,Seoul,Corea del Sud

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO

  • Jewish General Hospital, Montreal, QC, Canada

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • University of Pennsylvania, Philadelphia, PA

  • Samsung Medical Centre,Seoul,Корея, южная

  • Yale School of Medicine,New Haven, CT,Verenigde Staten

  • University of Pennsylvania, Philadelphia, PA

  • F. Hoffmann-La Roche Ltd., Shanghai, China

  • City of Hope,Duarte, CA,Estados Unidos

  • Linear Clinical Research and Sir Charles Gairdner Hospital, University of Western Australia, Nedlands, Australia

  • University of Pennsylvania,Philadelphia, PA,Vereinigte Staaten

  • Washington University School of Medicine Siteman Cancer Center,St Louis, MO,Vereinigte Staaten

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Yale School of Medicine, New Haven, Connecticut, United States

  • Hoffmann-La Roche Ltd,Mississauga, ON,Канада

  • Jewish General Hospital, Montreal, QC, Canada

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • F. Hoffmann-La Roche Ltd., Shanghai, China

  • City of Hope, Duarte, United States

  • Jewish General Hospital,Montreal,Канада

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • Fred Hutc

  • Yale School of Medicine,New Haven, CT,Stati Uniti

  • Yale University School of Medicine, New Haven, CT

  • University of Pennsylvania,Philadelphia, PA,Estados Unidos

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Samsung Medical Centre,Seoul,South Korea,Republic

  • Linear Clinical Research and Sir Charles Gairdner Hospital, University of Western Australia, Nedlands, Australia

  • Samsung Medical Center, Seoul, Republic of Korea

  • Genentech Inc.

  • City of Hope,Duarte,Vereinigte Staaten

  • Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Vereinigte Staaten

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

  • Yale School of Medicine,New Haven, CT,Stati Uniti

  • City of Hope,Duarte,Vereinigte Staaten

  • University of Pennsylvania,Philadelphia, PA,Vereinigte Staaten

  • F. Hoffmann-La Roche Ltd., Shanghai, China

  • Washington University School of...

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • Linear Clinical Research, Sir Charles Gairdner Hospital and The

  • Genentech, Inc.,South San Francisco, CA,Stati Uniti

  • Jewish General Hospital, Montreal, QC, Canada

  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

  • Samsung Medical Center, Seoul, Korea

  • Yale University School of Medicine,New Haven, CT,Estados Unidos

  • Genentech, Inc.,South San Francisco,Verenigde Staten

  • Yale School of Medicine,New Haven, CT,Verenigde Staten

  • Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO

  • Fred Hutchinson Cancer Research Center, Seattle, WA,Seattle, WA,Estados Unidos

  • Genentech Inc., San Francisco, United States

  • Linear Clinical Research and Sir Charles Gairdner Hospital, University of Western Australia, Nedlands, Australia

  • City of Hope,Duarte,États-unis

  • City of Hope, Duarte, CA

  • Hoffmann-La Roche Ltd, Mississauga, ON, Canada

  • University of Pennsylvania, Philadelphia, PA

  • City of Hope,Duarte,Stati Uniti

  • F. Hoffmann-La Roche Ltd., Shanghai, China

Locations

  • United Kingdom

  • Australia

  • United States

  • Canada

  • Republic of South Korea

  • China

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Autoimmune (AI)

  • Oncology (ONC)

Disease

  • B-Cell Non-Hodgkin Lymphoma

  • Cytokine release syndrome

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Lymphomas

Biomarkers

  • Twist-related protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT02500407

Sponsors

  • N/A

Result

  • N/A